Evolution of the Average Target: Almarai Company

Evolution of the Average Target - Almarai Company

Evolution of the Target Price: Almarai Company

Evolution of the Target Price - Almarai Company

Changes in Analyst Recommendations: Almarai Company

7e97b019fe89d57.zgW7_FmFC7pmxvqNDRGNdzg-rcYRkuEi2Fl6WfzKVWE.ijXwqBXORdhXmYrFaCH_Rmt91JBSoaxyqzZKI4aoIQ2eb_6VG8NtjBGWjQ~668fcbadac37349a4382a66e830b0ae8
12/10 United Securities Tweaks Almarai Co Price Target After Q3 Earnings Beat MT
06/10 Riyad Capital Keeps Almarai Co at Neutral Post-Q3 Earnings MT
28/08 AlphaMena Downgrades Almarai to Reduce Rating, Trims PT MT
21/08 Sadif Investment Analytics Upgrades Almarai to Hold, Raises PT MT
21/07 Al Rajhi Capital Lifts Almarai's PT, Affirms Neutral Rating MT
20/07 UBS Raises Almarai's PT, Affirms Neutral Rating MT
14/07 Citi Trims Almarai's PT, Affirms Buy Rating MT
10/07 AlphaMena Lifts Almarai's PT, Maintains Add Rating MT
07/07 Riyad Capital Affirms Almarai Co at Neutral After Q2 Results MT
02/07 AlphaMena Keeps Almarai at Add Rating, Lifts PT MT
25/06 EFG-Hermes Brokerage Raises Almarai PT, Keeps at Buy MT
04/06 Morgan Stanley Lifts Almarai's PT, Affirms Overweight Rating MT
01/06 BSF Capital Reduces Almarai's PT, Affirms Buy Rating MT
22/05 Sadif Investment Analytics Downgrades Almarai to Sell, Trims PT MT
18/05 EFG-Hermes Brokerage Lowers Almarai PT, Affirms Buy Rating MT
17/04 AlphaMena Lifts Almarai PT, Maintains Add Rating MT
16/04 United Securities Notes Almarai's Q1 Beat Despite Regional Tensions; Buy Rating Provided MT
10/04 FAB Securities Reduce Almarai's PT, Keeps at Buy MT
06/04 Arqaam Capital Reduces Almarai's PT, Affirms Buy Rating MT
03/04 AlphaMena Maintains Almarai at Add Rating, Lifts PT MT
01/04 Morgan Stanley Keeps Almarai at Overweight, Lowers PT MT
02/03 JPMorgan Lowers Almarai PT, Maintains Overweight Rating MT
20/02 AlphaMena Downgrades Almarai to Add, Reduces PT MT
20/02 Sadif Investment Analytics Reduces Almarai's PT, Affirms Hold Rating MT
03/02 Aljazira Capital Upgrades Almarai to Overweight, Reduces PT MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+29.12%
+13.7%
+12.2%
+33.68%
-3.61%
+23.65%
+19.48%
+18.92%
+12.57%
Average +17.74%
Weighted average by Cap. +15.29%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
43.00SAR
Average target price
56.40SAR
Spread / Average Target
+31.16%
High Price Target
68.00SAR
Spread / Highest target
+58.14%
Low Price Target
50.00SAR
Spread / Lowest Target
+16.28%

Analyst Consensus Detail

Analyst consensus - Almarai Company

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Almarai Company
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Almarai Company
  1. Stock Market
  2. Stocks
  3. 2280 Stock
  4. Consensus Almarai Company